SPE Capital and Proparco exit Moroccan pharmaceutical group Amanys Pharma

By AfricaPost November 25, 2023185 views

Only three years after joining the shareholding of Amanys Pharma, a Moroccan antibiotics manufacturer and hospital supplier, private equity firm SPE

Source

Comments

Comments are closed.

More in Business

Business

Top Five Reasons to Attend IAE 2025 in Paris

1 day ago0

Business

HomeChoice bets on smaller showrooms as earnings jump

1 day ago0

Business

Axian Energy Green achieves a “C” score for its first CDP reporting

1 day ago0

Business

MTN Ghana Posts Strong Subscriber Growth Amid Challenging Economy

2 days ago0

SPE Capital and Proparco exit Moroccan pharmaceutical group Amanys Pharma

United Arab Emirates President sends letter to President of Nigeria

A DEPUTY COUNTRY DIRECTOR – SUPPORT, November 2023 – NGO Jobs

Uganda: Africa Finance Corporation Looking to Finance Orom-Cross Graphite Mine

Nigerian stock exchange hopes for Flutterwave IPO boost

New Renault Duster arrives in SA

Laham Tchad designated as an AfCFTA pilot company

Comments

More in Business

Top Five Reasons to Attend IAE 2025 in Paris

HomeChoice bets on smaller showrooms as earnings jump

Axian Energy Green achieves a “C” score for its first CDP reporting

MTN Ghana Posts Strong Subscriber Growth Amid Challenging Economy

Popular Posts

Family-owned florist business looks to bloom in Chestertown

Review: Nokia retunes 3310 for a new generation

Apple Watch: What does the future hold?

Asian stocks pull back on U.S. tech declines, eurozone worries

United Arab Emirates President sends letter to President of Nigeria

A DEPUTY COUNTRY DIRECTOR – SUPPORT, November 2023 – NGO Jobs

You may also like

Comments

More in Business

Popular Posts